heart failure

Lexicon's Inpefa safe and effective for HF, large-scale trial shows
Clinical Trials Arena
Wed, 08/16/23 - 11:25 pm
Lexicon
clinical trials
heart failure
Inpefa
Biocardia takes a pause for thought
EP Vantage
Tue, 07/25/23 - 10:05 am
BioCardia
CardiAMP
stem cell therapy
heart failure
Lexicon gets FDA approval for Inpefa to treat heart failure
Pharmaceutical Technology
Mon, 05/29/23 - 12:14 pm
Lexicon Pharmaceuticals
FDA
Inpefa
heart failure
Farxiga’s approval for expanded use highlights potential to differentiate in HF space
Clinical Trials Arena
Fri, 05/12/23 - 11:42 am
AstraZeneca
Farxiga
heart failure
Boehringer Ingelheim and Eli Lilly's Jardiance gets big lift from heart failure indications
Fierce Pharma
Wed, 03/29/23 - 04:01 pm
Boehringer Ingelheim
Eli Lilly
Jardiance
heart failure
FDA turns down Cytokinetics’ once-promising heart failure drug omecamtiv
Fierce Pharma
Tue, 02/28/23 - 10:51 pm
Cytokinetics
heart failure
FDA
complete response letter
Omecamtiv Mecarbil
Novo sows the seeds for a new heart failure approach
EP Vantage
Wed, 02/22/23 - 09:50 am
Novo Nordisk
HS-001
cell therapy
heart failure
Heart hope for Heartseed/Novo Nordisk HS-001 cell therapy
Pharmaphorum
Fri, 02/10/23 - 10:21 am
Novo Nordisk
Heartseed
clinical trials
HS-001
cell therapy
heart failure
AstraZeneca's Forxiga nabs expanded heart failure approval in Europe
Fierce Pharma
Tue, 02/7/23 - 06:41 pm
AstraZeneca
Europe
Forxiga
heart failure
FDA advisers nix Cytokinetics' heart failure med, rejecting argument for subgroup use
Fierce Biotech
Tue, 12/13/22 - 11:56 pm
FDA
Cytokinetics
heart failure
Omecamtiv Mecarbil
Ahead of adcomm, FDA raises uncertainties on benefit-risk profile of Cytokinetics' potential heart drug
Endpoints
Sun, 12/11/22 - 01:28 pm
FDA
Cytokinetics
heart failure
Omecamtiv Mecarbil
Abbott’s HeartMate 3 extends life by 5 years for advanced heart failure patients
MedCity News
Tue, 09/20/22 - 10:17 am
Abbott Labs
Medtech
devices
HeartMate 3
advanced heart failure
heart failure
Bayer’s BlueRock inks cardiovascular cell therapy delivery deal
Fierce Pharma
Wed, 08/31/22 - 10:22 am
Bayer
BlueRock Therapeutics
heart failure
cell therapy
BioCardia
Abbott Gets to the Heart of Extending Life-Expectancy with HeartMate 3 Data
Medical Devices and Diagnostics Industry
Tue, 08/30/22 - 11:59 am
Abbott Labs
devices
Medtech
heart failure
HeartMate 3
AstraZeneca’s Farxiga reduces CV mortality risk in Phase III trials
Clinical Trials Arena
Mon, 08/29/22 - 11:01 am
AstraZeneca
Farxiga
clinical trials
heart failure
Cytokinetics aims to become the Vertex of cardiovascular disease
EP Vantage
Thu, 06/16/22 - 10:19 am
Cytokinetics
Amgen
heart failure
Omecamtiv Mecarbil
cardiovascular disease
Will third time be the charm? Lexicon finally refiles SGLT2 drug for heart failure
Endpoints
Tue, 05/31/22 - 11:58 pm
Lexicon Pharmaceuticals
sotagliflozin
heart failure
FDA
AZ bites back at rivals with new Farxiga data in heart failure
Pharmaforum
Thu, 05/5/22 - 10:16 am
AstraZeneca
Farxiga
heart failure
clinical trials
CEO of cardiology startup declares that its tech could potentially cure heart failure
MedCity News
Sat, 04/30/22 - 02:30 pm
Ceryx
cardiology
startups
heart failure
Medtech
devices
Cysoni
ACC: Lexicon hopes sotagliflozin cardio data will set its drug apart from SGLT2 rivals
Fierce Pharma
Mon, 04/4/22 - 10:59 am
Lexicon Pharmaceuticals
ACC
diabetes
sotagliflozin
type 2 diabetes
heart failure

Pages